APGE R&D Expenses

Apogee Therapeutics Inc · R&D Expenses

APGE logo

APGE R&D Expenses

Latest reported$240.74M
APGE R&D Expenses ($27.79M → $240.74M)
High-resolution chart · PNG

APGE r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Apogee Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
214,712,000
167,865,000
68,424,000
27,786,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.